We isolated 105 strains of lactic acid bacteria (LAB) from home-made kimchi and breast milk-fed Korean infant feces on the basis of morphological analysis. This study aimed to compare the probiotic characteristics of selected strains of LAB including bile and acid tolerances, cholesterol assimilation and adhesion activity. Among the isolates of LAB, 54 isolates were identified as Lactobacillus plantarum (14 strains), L. brevis (12 strains), L. sakei (9 strains), L. acidophilus (3 strains), L. casei (1 strain), and L. fermentum (1 strain). Acid tolerances under artificial gastric juice, pH 2.5 for 2 h at 37°C, were significantly different among the Lactobacillus species. Lactobacillus acidophilus and L. plantarum strains exhibited high tolerance in acid and bile. Lactobacillus acidophilus strains exhibited high cholesterol assimilation activity and showed a significantly higher tolerance to 0.3% bile acid than other Lactobacillus strains (p<0.05). Based on these results, we selected the best strain, named NS1 (L. acidophilus) as a potential probiotics that can be utilized in the manufacturing of dairy foods and dietary supplements.

We isolated 105 strains of lactic acid bacteria (LAB) from home-made kimchi and breast milk-fed Korean infant feces on the basis of morphological analysis. This study aimed to compare the probiotic characteristics of selected strains of LAB including bile and acid tolerances, cholesterol assimilation and adhesion activity. Among the isolates of LAB, 54 isolates were identified as Lactobacillus plantarum (14 strains), L. brevis (12 strains), L. sakei (9 strains), L. acidophilus (3 strains), L. casei (1 strain), and L. fermentum (1 strain). Acid tolerances under artificial gastric juice, pH 2.5 for 2 h at 37°C, were significantly different among the Lactobacillus species. Lactobacillus acidophilus and L. plantarum strains exhibited high tolerance in acid and bile. Lactobacillus acidophilus strains exhibited high cholesterol assimilation activity and showed a significantly higher tolerance to 0.3% bile acid than other Lactobacillus strains (p<0.05). Based on these results, we selected the best strain, named NS1 (L. acidophilus) as a potential probiotics that can be utilized in the manufacturing of dairy foods and dietary supplements.

피부의 피부 노화, 질환, 훼손은 내부적인 요인으로서 활성산소라는 사실이 밝혀진 이래로 합 성 항산화제를 대체할 수 있는 천연물 항산화제에 대하여 많은 연구가 진행 중이다. 이들 중에 지실은 오래전부터 만성적인 염증, 알리지 완화, 황산화 기능을 하는 것으로 알려져 왔다. 미생물을 이용한 발 효는 조직에 결합 되어 있는 생리활성 물질의 유리로 생체이용율(bioavailability) 훨씬 높아지는 것으로 알려 졌다. 따라서 본 연구는 지실 열수 추출물을 기질로 GRAS 알려진 균주를 이용하여 발효를 수행하 고 발효가 항산화 능력에 미치는 영향에 대하여 알아보고자하였다. 지실 열수 추출물은 항산화 기능을 가지고 있는 hesperidine, naringine, luteoilin, imperatorin등의 플라보노이드 및 furocoumarin등이 동정 이 되었고 함유량은 hesperidine naringine, imperatorin, luteolin 순이었다. 열수 추출물을 기질로 하여 분리된 Leuconostocs sp. strain JYK로 발효를 수행한 결과 지실 열수 추출물을 사용한 경우에는 71.2±4.58 (mg/g)의 총 페놀 함량이 있는 것으로 측정이 되었고 반면에 발효 추출물에는 89.2±13.47 (mg/g)으로 약 25.3% 증가된 것으로 나타났다. 총 플라보노이드 화합물은 지실 열수 추출물에는 25.1±4.12 (mg/g)의 총 플라보노이드 함량이 있는 것으로 측정이 되었고 반면에 발효 추출물에는 31.0±4.06 (mg/g)으로 약 23.5% 증가된 것으로 나타났다. DPPH 소거능은 지실 열수 추출물에는 70.9% 반면에 발효 추출물은 86.2% 측정이 되었다. 총 항산화 능력은 18.7% 발효추출은 26.6%로 발 효를 통하여 약 40% 증가하였다. 따라서 미생물 발효를 통하여 천연물에 포함이 되어있는 기능성 물질 에 대한 생체 이용률을 높인다면 산화적 스트레스에 의한 피부 노화 완화 및 개선 작용으로 기능성 화 장품 및 식품의 소재로 활용 가치를 높여 줄 것으로 기대를 한다.

Antibiotics have been used to prevent disease, promote growth rate, and improve feed efficiency. However, the use of antibiotics in livestock has been restricted worldwide due to problems such as bacterial resistance. Therefore, probiotics among alternatives to antibiotics have gained attention in the livestock feed industry these days. This study was conducted to investigate the effects of dietary supplementation with probiotic 379D on safety, growth rate, and feed efficiency. In this study, bacterial strain 379D was isolated from soil and identified as a Bacillus sp. according to 16S rRNA sequence analysis. In an in vitro test, in-gel activity assay and antimicrobial susceptibility test were conducted to evaluate 379D. In an in vivo study, 379D was administered at concentrations of 0.1% and 1% to broiler chickens for 28 days. The results of in-gel activity assay and antimicrobial susceptibility test showed that strain 379D had broad spectrum antimicrobial activity. Furthermore, no adverse 379D-related effects were observed in 0.1% and 1% groups. Feed efficiency was higher in the 379D-treated groups than in the control group. In conclusion, 379D is expected to be used as a safe alternative to antibiotics in a feed supplement and will improve feed efficiency in broiler chickens.

본 연구는 산국 생균제가 비육후기 거세한우의 성장율과 육질에 미치는 효과를 조사하기 실시하였다. 거세한우 15두(565±17kg)를 시험구별 개시체중이 유사하도록 산국 생균제 무첨가구(CON), 농후사료의 0.2% 첨가구(LCB) 및 0.4% 첨가구(HCB)에 각 5두씩을 배치하고 150일간 사양시험을 실시하였다. 농후사료와 조사료를 8:2의 비율로 설정하고 생체중의 약 2.5%를 오전(8시)과 오후(5시)로 나누어 급여하였다. 미네랄 블록과 음수는 자유로이 섭취할 수 있도록 하였다. 사양시험 종료 후에는 모든 공시동물은 도축하여 도체특성을 조사하고 등심육을 채취하여 육질분석에 이용하였다. 개시체중과 종료체중은 처리구간 차이가 없었으나, 일당증체량, 사료섭취량 및 사료효율은 산국 생균제를 급여한 모든 시험구에서 대조구에 비해 개선되었다(p<0.05). 분 중 황화수소와 암모니아 가스는 시험구간 차이가 없었다. 신선육 관능평가에서 등심육의 육색은 산국 생균제를 급여한 시험구가 개선되었으나(p<0.05), 등심육의 물리화학적 특성과 기타 신선육 관능평가는 시험구간 차이가 없었다. 등심육의 지방산 조성은 산국 생균제를 급여한 시험구에서 C14:0과 C18:0 함량이 증가하였으며(p<0.05), HCB 시험구에서 C18:2n-6와 polyunsaturated fatty acid 함량은 HCB 시험구에서 가장 높게 나타났다(p<0.05). 따라서 비육후기 거세한우에 산국 생균제를 0.4% 수준으로 급여하는 것은 사료효율 개선, 육색 및 등심육 지방산 품질개선에 유리할 것으로 사료된다.

A 7-year-old spayed female English Cocker Spaniel dog presented with polyuria (PU), polydipsia (PD), intermittent vomiting, and weight loss. Physical examination revealed pale, tacky mucous membranes and severe emaciation. Hematological and biochemical examinations revealed moderate normocytic normochromic non-regenerative anemia and moderate azotemia. Abdominal ultrasonography demonstrated bilaterally small lumpy-bumpy kidneys with hyperechoic parenchyma as well as loss of renal corticomedullary junction. Based on clinical history and examinations, the dog was diagnosed with chronic kidney disease (CKD). The dog was treated with supportive care including fluid therapy, phosphate-binding agent, and histamine H2-receptor antagonist. Darbepoetin Alfa was administered to control renal secondary non-regenerative anemia. Prescribed diet with low-protein and low-phosphorus was fed to alleviate CKD signs. Further, dietary probiotics were supplemented. This case demonstrates that oral probiotic supplementation helped reduce blood urea-nitrogen (BUN) levels. This case indicates that dietary probiotics can be a potential alternative therapeutic agent for management of renal failure

In this study, characteristics and immuno-modulatory effects of Weissella cibaria JW15 isolated from Kimchi, traditional Korean fermented food, were examined for investigation of the capacity of potentially probiotic strains. We measured acid, bile, and heat tolerance, adhesive properties to intestinal epithelial cells, and inhibitory activity against pathogens. JW15 could survive at pH 3.0 for 2 hr, but not at pH 2.0. JW15 also showed tolerance to 0.3% oxgall bile salt, and heat tolerance at 70°C and 80°C for 5 min, respectively. Adhesive ability to Caco-2 cells was similar to that of Lactobacillus rhamnosus GG (LGG), a well-known commercial probiotic. JW15 exhibited antimicrobial activities to pathogenic bacteria such as Escherichia coli, Listeria monocytogenes, Staphylococcus aureus, and Salmonella enteritidis. The immuno-modulatory effects of JW15 were compared with those of LGG, a well-known immune enhancer. For analysis, production of nitric oxide (NO), NF-κB (Nuclear factor κB), Interleukin-1β (IL-1β), and tumor necrosis factor-α (TNF-α) was measured. The concentration of NO induced by JW15 was higher than that by LGG at low concentration (1 × 107 cfu/mL). Low and high (5 × 107 CFU/mL) concentration of JW15 induced statistically higher production of NF-κB, IL-1β, and TNF-α than that produced by LGG, respectively. In conclusion, Weissella cibaria JW15 had ability as a probiotic strain, including acid, bile, and heat tolerance, adhesive properties to intestinal epithelial cells, and inhibitory activity against pathogens. In addition, JW15 showed better immuno-modulatory effects than LGG when NO, NF-κB, IL-1β, and TNF-α were measured. According to these results, the characteristics and immunomodulating activity of Weissella cibaria JW15 are suitable for consideration as a potential probiotic.

In the livestock feed industry, antibiotics are used to prevent disease, promote growth rate, and improve feed efficiency. However, antibiotic supplementation to animal feed results in increased bacterial resistance to antibiotics as well as antibiotic residues in animal products, which can negatively affect human health. Therefore, alternative sources of antibiotics are need- ed. Probiotics as an alternative to antibiotics in animal feed have been shown to increase feed efficiency and growth rate by improving microbial balance. Further, Bacillus sp. produces a wide spectrum of antibacte- rial peptides. The present study was conducted to investigate the effects of dietary supplementation with CS-32 on safety, growth rate, and feed efficiency. Antibacterial substance (5697.9 molecular weights) produced by CS-32 was isolated and purified from culture broth. Moreover, the results of minimal inhibi- tory concentration (MIC) test confirmed the excellent antibacterial effect of CS-32. In vivo, 0.1% and 1% CS-32 were fed to broiler chickens for 28 days. Feed efficiency was slightly higher in groups of chickens supplemented with 0.1% and 1% CS-32 than those of the control group. CS-32 had no significant effect on necropsy findings, hematology, or serum biochemistry, and there was no mortality. These results suggest that CS-32 among various biologically active substances may be safe and effective as a feed additive to improve growth rate and feed efficiency.

동아(冬瓜, wax gourd, Benincase hispida) 추출물과 프로바이오틱 유산균(Lactobacillus casei와 Bifidobacterium bifidum) (이하 유산균이라 한다)의 생리활성을 분석하였다. 동아 추출물은 안기오텐신전환효소의 활성을 47.9%, 티로시나제의 활성을 13.2% 저해하였고, 항산화 활성을 23.4% 나타냈다. 설사 증세자 120명에게 동아 추출물 제제를 72시간 복용시킨 결과 117명이 개선되었고, 6∼12시간째에 개선율이 가장 높았다. 개선율은 80%가 치료되는 상태를 기준하였다. 유산균제제는 안기오텐신전환효소의 활성을 21.4% 저해하였다. 설사 증세자 120명에게 유산균 제제를 72시간 복용시킨 결과 108명이 개선되었고, 24시간째에 개선율이 가장 높았다. 이들 결과를 바탕으로, 과민성대장증후군 개선을 위한 동아 추출물과 유산균을 함유한 제제(tablet)를 개발하였다. 이 제품은 안기오텐신전환효소의 활성을 27.1% 저해하였고, 항산화 활성을 20.3% 나타냈다. 인체폐암 A549 세포에 100 ㎍/㎖ 및 250 ㎍/㎖ 농도로 이 제제를 가하여 24시간 반응시킨 결과, 세포 증식을 67% 억제하였고, 동아 추출물 제제나 프로바이오틱 유산균 제제 단독으로 작용시킨 것보다 억제율이 높았다. 또 이 제제를 인체대장암 HCT116 세포에 100 ㎍/㎖ 농도로 가한 결과, 24시간 후 세포 증식이 70% 억제되었고, 동아 추출물 제제나 유산균 제제 단독으로 작용시킨 것보다 개선율과 개선 속도가 높았다. 이 제제를 설사형, 변비형, 일반형의 과민성대장증후군 증세자 164명에게 72시간 복용시킨 결과 100% 개선시켰으며, 개선율은 3∼6시간째에 가장 높았고, 동아 추출물 제제나 유산균 제제 단독으로 사용한 것보다 개선율과 개선속도가 높았다.

In Japan, milk and food companies have recently developed many functional yogurts using selected probiotic lactic acid bacteria (LAB) and Bifidobacterium strains. In 1991, the FOSHU (foods for specified health uses) system began instituted by the Ministry of Health, Labor and Welfare. In 2010, approximately 1,000 commercially available items were labeled as FOSHU products that are specially given brands showing good health effects for humans. Japanese commercial yogurts are classified into three type categories: fermented using selected probiotics, functional components added, and standard types. Many functions are considered in the selection of probiotics including competitive adhesion exclusion of enteritic pathogens, cholesterol lowering effects, and positive immuno-modulatory effects. Adhesion to the human intestine is one of the most important characteristics of probiotic LAB and bifidobacteria. Our new screening system for adhesive activity involves a combination of three methods: the rat colonic mucin-micro plate assay, the Carnoy’s histochemical staining method, and the carbohydrate probe binding assay. Recently, we developed a new screening assay using the BIACORE biosensor chip coated with human colon mucin (HCM). We found new LAB strains that recognize and specifically bind to the human ABO blood type antigens. We named these “blood type LAB”. We identified the molecular LAB binding mechanism occurring in the human intestine through unique adhesin molecules that are expressed on the bacterial cell surface as lectin-like proteins. Bacteria with strong adhesion ability improve gastrointestinal health by continuous proliferation in the intestine; and increase the chance of intake into the Peyer’s patches through M-cells that inhibit allergies because of LAB immune-stimulating activity. The future Japanese food market will contain superior functional yogurts containing adhesive effective probiotic LAB and bifidobacteria that are expected to be developed using our proposed mass screening system shown here.

Probiotics, enzymes, organic acids, oligosaccharides, antioxidants, and other functional materials are actively being explored as alternatives to antibiotics. Probiotics include live beneficial microorganisms that colonize the intestinal tract and competitively inhibit attachment and growth of harmful microbes. Probiotics also increase feed efficiency by assisting in nutrient absorption and digestion. The current study was conducted in order to evaluate the effect of a new probiotic, CS-A, as a dietary supplement of a fermented product on growth performance, feed intake, and feed conversion efficiency in broiler chickens, and to evaluate its value as an alternative for antibiotics used as a feed additive. Antibacterial and anti-inflammatory effects of CS-A were investigated in vitro and the in vivo effects of a constant concentration of supplemented CS-A on growth rate and feed efficiency were evaluated. In addition, the safety of CS-A was assessed by examination of common symptoms and mortality. Determination of minimal inhibitory concentration revealed an excellent antibacterial effect of CS-A. Cytotoxicity was low and anti-inflammatory effects were achieved at the effective concentration of CS-A. Supplementation with 0.1% CS-A resulted in a feed efficiency score of 1.84 in broilers, compared to 2.00 in the control group. There were no adverse clinical findings, necropsy findings, hematology, and altered serum biochemistry parameters, and no mortality. Thus, it is concluded that CS-A is safe and effective as a feed additive.

To investigate the influence of multi-probiotic, fermented ginseng byproduct and fermented sulfone on the performance, intestinal microflora and immunity of broiler, a five weeks trial was conducted with 340, 1-d-old Ross×Ross broiler. All broilers were divided into five different groups having 68 birds in each treatment, and they were assigned as control, antibiotic avilamycin (AB), multi-probiotic (MP), fermented sulfone (FS) and fermented ginseng byproduct (FGB). Each artificial or naturally derived probiotic was inoculated 0.1% level with the basal diet, and all diets were provided to birds for five weeks. Weight gain and feed intake were measured weekly basis, and blood, spleen and feces were collectedand used for the physiological properties of broiler chickens. All performances and cholesterol profiles were not significantly differed but numerically lower level of neutral fat and LDL was found in multi-probiotics and FGB treatments respectively. The salmonella spp and E. coli numbers in the ileum were high in control in relation to those of other treatments and were significantly decreased in antibiotics treatments (p<0.05). In addition, Lactobacillus spp. showed significantly higher proliferation in MP as compared to that of others (p<0.05). Fecal ammonia and CO2 gas emission was significantly decreased in MP, FGB and FS, respectively (p<0.05), but significantly increased proliferation of spleen was determined in MP group in comparison of other treatments (p<0.05). Therefore, the results indicates that multi-probiotics would be valuable feed additives to improve the salmonella, E. coli and Lactobacillus proliferation, and manure gas emission of broiler chickens, but further study related to the production of manure gas emission of MP is necessary.

본 연구는 probiotics 균주 선발을 위해 동치미로부터 식중독균에 대해 높은 항균활성을 보이는 유산균을 분리동정하여 배양조건을 확립하고, 위산, 담즙산, 췌장액에 대한 저항성 실험을 비교, 분석하여 probiotics 균주로 사용 가능성을 탐색하고자 하였다. 2% CaCO3를 첨가한 MRS agar를 이용하여 김치 무리로부터 식중독균의 저해능이 우수한 8 균주를 분리하였다. 식중독균에 대해 항균활성실험 결과 J4가 B. cereus는 19.85±0.53 mm, L. monocytogenes는 18.37±0.38 mm, S. aureus는 22.49±0.37 mm, E. coli는 17.90±0.64 mm, S. enterica는 16.28±0.53 mm, V. parahaemolyticus는 24.59±0.29 mm의 생육저해환을 형성하여 가장 높은 항균력을 나타내었다. J4 균주의 16S rDNA 염기서열을 분석한 결과 L. sakei와 99% 상동성을 나타내어 L. sakei J4라 명명하였다. L. sakei J4의 최적배양조건은 pH 8.5, 30, 정치배양시 가장 활발하게 생육이 진행됨을 확인하였다. L. sakei J4는 인공위액에서의 생존율 24.3±3.0%, 담즙산에서의 생존율 25.8±0.4%, 췌장액에서의 생존율 101.2±4.5%로 다른 균주보다 상대적으로 생존율이 높았으며, 향후 alginate를 이용한 캡슐화, chitosan을 이용한 재코팅 등의 연구방법을 정립하여 인공위액에 대한 저항성을 높인다면 프로바이오틱스 균주로서 조건을 충족시킬 수 있으리라 사료된다.

Probiotics는 살아있는 미생물로서 섭취했을 때 숙주에게 건강증진효과를 나타내는 미생물이다. 식품 및 제약에서 가장 많이 사용되는 probiotics로는 Lactobacillus와 Bifidobacterium 균주가 있다. 이 유산균들은 장내 정상균총의 유지, 설사 예방 및 개선, 항암, 항대장염, 면역조절, 항고지혈, 항당뇨 효과 등 많은 건강증진 효과를 나타낸다. 최근에 장내 미생물이 에너지 대사, 특히 지방 대사에 영향을 주어 체중을 조절하는데 있어 중요한 역할을 한다는 것이 알려졌다. 이와 더불어 몇몇 probiotic Lactobacillus가 비만 실험동물 뿐만 아니라 비만인에서도 체지방을 조절하는 것으로 나타나 당뇨 및 비만 등과 같은 대사성질환의 예방 및 치료에 있어 유산균의 사용 가능성이 점쳐지고 있다. 그러나 유산균의 항비만 효과 그리고 그에 관한 기전에 대해서는 많은 연구들이 수행되지 않았다. 따라서 유산균의 항비만 효과를 검증하기 위해서는 앞으로 이에 관한 기전에 대해 더 많은 연구들이 진행되어야 하고 궁극적으로 사람에서 그 효과가 검증되어야할 것이다.